IL166773A0 - Pravastatin pharmaceutical formulations and methods of their use - Google Patents

Pravastatin pharmaceutical formulations and methods of their use

Info

Publication number: IL166773A0
Authority: IL; Israel
Prior art keywords: methods; pharmaceutical formulations; pravastatin; pravastatin pharmaceutical; formulations
Prior art date: 2002-09-03

Application number

IL16677305A

Other languages

English (en)

Original Assignee

Biovail Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-03

Filing date

2005-02-09

Publication date

2006-01-15

2005-02-09 Application filed by Biovail Lab Inc filed Critical Biovail Lab Inc

2006-01-15 Publication of IL166773A0 publication Critical patent/IL166773A0/xx

Links

TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 title 1
229960002965 pravastatin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Obesity (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IL16677305A 2002-09-03 2005-02-09 Pravastatin pharmaceutical formulations and methods of their use IL166773A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40726902P	2002-09-03	2002-09-03
PCT/IB2003/004523 WO2004021973A2 (en)	2002-09-03	2003-09-03	Pravastatin pharmaceutical formulations and methods of their use

Publications (1)

Publication Number	Publication Date
IL166773A0 true IL166773A0 (en)	2006-01-15

Family

ID=31978448

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16677305A IL166773A0 (en)	2002-09-03	2005-02-09	Pravastatin pharmaceutical formulations and methods of their use

Country Status (10)

Country	Link
US (1)	US20040132806A1 (de)
EP (2)	EP1551356A2 (de)
JP (1)	JP2006504686A (de)
AU (1)	AU2003267756A1 (de)
CA (1)	CA2497896A1 (de)
IL (1)	IL166773A0 (de)
MX (1)	MXPA05002095A (de)
NO (1)	NO20050933L (de)
PL (1)	PL375712A1 (de)
WO (1)	WO2004021973A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8987322B2 (en)	2003-11-04	2015-03-24	Circ Pharma Research And Development Limited	Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
RU2697851C2 (ru) *	2014-08-13	2019-08-21	Седарс-Синаи Медикал Сентер	Антиметаногенные композиции и их применение
EP3277274B1 (de)	2015-04-01	2024-06-12	Cedars-Sinai Medical Center	Antimethanogene lovastatin-analoga oder -derivate und verwendungen davon

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US3916899A (en)	1973-04-25	1975-11-04	Alza Corp	Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en)	1974-11-18	1977-07-06	Alza Corp	Process for forming outlet passageways in pills using a laser
US4200098A (en)	1978-10-23	1980-04-29	Alza Corporation	Osmotic system with distribution zone for dispensing beneficial agent
US4557925A (en)	1982-07-08	1985-12-10	Ab Ferrosan	Membrane-coated sustained-release tablets and method
US4629620A (en) *	1984-09-05	1986-12-16	Ab Ferrosan	Membrane-coated sustained-release tablets and method
US4904474A (en) *	1988-01-25	1990-02-27	Alza Corporation	Delivery of drug to colon by oral disage form
US5030447A (en) *	1988-03-31	1991-07-09	E. R. Squibb & Sons, Inc.	Pharmaceutical compositions having good stability
US4997658A (en) *	1988-11-21	1991-03-05	Merck & Co., Inc.	Method for enhancing the lowering of plasma cholesterol levels
CA2045428A1 (en) *	1990-06-26	1991-12-27	Alfred W. Alberts	Method for enhancing the lowering of plasma cholesterol levels
US5225202A (en) *	1991-09-30	1993-07-06	E. R. Squibb & Sons, Inc.	Enteric coated pharmaceutical compositions
US5573776A (en)	1992-12-02	1996-11-12	Alza Corporation	Oral osmotic device with hydrogel driving member
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
KR19990087376A (ko) *	1996-02-29	1999-12-27	라르스 헨릭 회이에	식품 보충제 또는 혈청 지질 감소용 조성물 및 그의 용도
US6056977A (en) *	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
US5916595A (en) *	1997-12-12	1999-06-29	Andrx Pharmaceutials, Inc.	HMG co-reductase inhibitor
UA69413C2 (uk) *	1998-05-22	2004-09-15	Брістол-Майерс Сквібб Компані	Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
UA73092C2 (uk) *	1998-07-17	2005-06-15	Брістол-Майерс Сквібб Компані	Таблетка з ентеросолюбільним покриттям і спосіб її приготування
WO2000033821A1 (en) *	1998-12-07	2000-06-15	Bristol-Myers Squibb Company	Enteric coated pravastatin bead formulation
SI20109A (sl) *	1998-12-16	2000-06-30	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Stabilna farmacevtska formulacija
US6569461B1 (en) *	1999-03-08	2003-05-27	Merck & Co., Inc.	Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
US6592890B1 (en) *	1999-10-20	2003-07-15	Oxibio, Inc.	Conveyance of anti-infective activity to wound dressings
CA2404044A1 (en) *	2000-04-11	2001-10-18	Atherogenics, Inc.	Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality

2003
- 2003-09-03 EP EP03748451A patent/EP1551356A2/de not_active Ceased
- 2003-09-03 PL PL03375712A patent/PL375712A1/xx unknown
- 2003-09-03 US US10/653,415 patent/US20040132806A1/en not_active Abandoned
- 2003-09-03 AU AU2003267756A patent/AU2003267756A1/en not_active Abandoned
- 2003-09-03 JP JP2004533791A patent/JP2006504686A/ja active Pending
- 2003-09-03 EP EP08157599A patent/EP2033631A3/de not_active Withdrawn
- 2003-09-03 WO PCT/IB2003/004523 patent/WO2004021973A2/en not_active Ceased
- 2003-09-03 MX MXPA05002095A patent/MXPA05002095A/es unknown
- 2003-09-03 CA CA002497896A patent/CA2497896A1/en not_active Abandoned
2005
- 2005-02-09 IL IL16677305A patent/IL166773A0/xx unknown
- 2005-02-21 NO NO20050933A patent/NO20050933L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1551356A2 (de)	2005-07-13
CA2497896A1 (en)	2004-03-18
WO2004021973A3 (en)	2004-05-21
NO20050933L (no)	2005-04-18
EP2033631A2 (de)	2009-03-11
EP2033631A3 (de)	2009-06-03
US20040132806A1 (en)	2004-07-08
JP2006504686A (ja)	2006-02-09
PL375712A1 (en)	2005-12-12
AU2003267756A1 (en)	2004-03-29
WO2004021973A2 (en)	2004-03-18
MXPA05002095A (es)	2005-06-06

Publication	Publication Date	Title
PL377854A1 (pl)	2006-02-20	Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
EP1479666A4 (de)	2010-10-13	Esterverbindung und deren medizinische verwendung
PL375833A1 (en)	2005-12-12	Pharmaceutical formulations of modafinil
PL375052A1 (en)	2005-11-14	Pharmaceutical pig and method of use
AU2003272601B2 (en)	2009-05-07	Sustained-release opioid formulations and methods of use
HUP0400384A3 (en)	2008-08-28	Benzamidine derivative and pharmaceutical compositions containing them and their use
SI1562556T1 (sl)	2013-05-31	Farmacevtski sestavki in dozirne oblike talidomida
IL162937A0 (en)	2005-11-20	Pravastatin pharmaceutical formulations and methods of their use
IL163868A (en)	2011-11-30	Hemiasterlin derivatives and pharmaceutical compositions comprising them
IL166772A0 (en)	2006-01-15	Pharmaceuticals formulations and methods for modified release of statin drugs
GB0108470D0 (en)	2001-05-23	Pharmaceutical compositions and their use
GB0202900D0 (en)	2002-03-27	Novel formulations of drugs
IL211958A0 (en)	2011-06-30	Lactone formulations and method of use
AU2003239868A8 (en)	2003-12-12	Sunscreen compositions and methods of use thereof
SI1556026T1 (sl)	2009-12-31	Nove farmacevtske formulacije modafinila
AU2002359618A1 (en)	2003-06-23	Medicinal compositions and therapeutic methods
AU2003287546A8 (en)	2004-06-07	Synthetic lactone formulations and method of use
ZA200603542B (en)	2007-02-28	Oral formulations of desoxypeganine and uses thereof
EP1534293A4 (de)	2009-09-16	Entzündungshemmende zusammensetzungen und anwendungsverfahren
IL166773A0 (en)	2006-01-15	Pravastatin pharmaceutical formulations and methods of their use
AU2003295713A8 (en)	2004-06-15	Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
EP1539117A4 (de)	2005-12-14	Formulierungen aus fenofibrat und/oder fenofibrat-derivaten mit verbesserter bioverf gbarkeit
AU2003291458A8 (en)	2004-06-03	Pharmaceutical compositions and methods of using taxane derivatives
HK1082665A (en)	2006-06-16	Pravastatin pharmaceutical formulations and methods of their use
AU2003290647A8 (en)	2004-06-03	Pharmaceutical compositions and methods of using taxane derivatives